Immunovant · 20 hours ago
Director, Clinical Pharmacology
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. The Director of Clinical Pharmacology is responsible for providing strategic and scientific expertise, collaborating with cross-functional teams, and delivering the tactical execution of the Clinical Pharmacology strategy for clinical development programs.
Responsibilities
Develop and maintain comprehensive CP strategic development plans for all clinical development programs/studies
Provide expert-level CP and expert to the clinical study team/development team
Collaborate with Quantitative Pharmacology (QP) vendors or colleagues to develop and deliver quantitative strategies to support assigned development plans
Formulate and finalize CP related report templates, as well as data handling and analysis standard operating procedures (SOP)
Contribute to the drafting, review, and finalization of clinical study protocols and study analysis plans (SAP)
Supervise and/or conduct pharmacokinetic/pharmacodynamic (PKPD) and biomarker analyses, ensuring high-quality and accurate results
Lead the drafting, reviewing, and finalizing CP study reports and publications, collaborating with the Medical Writers to incorporate CP-related sections into clinical study reports (CSR)
Collaborate closely with Regulatory to provide CP support of regulatory documents, communications, and presentations as needed (IND, health authority inquires, preparation/participation in meetings with health authorities, preparation of relevant BLA sections, addressing review inquiries, health authority sponsored Advisory Committee Meetings)
Support cross-functional teams, including Statistics, Data Management, Clinical, Preclinical/Nonclinical, Translational Science, as needed
Qualification
Required
PhD, PharmD, or MD with training in CP, PK/PD, Pharmacology, and Pharmaceutical Sciences
5+ years of experience in the application of CP within the context of drug development in the healthcare industry
Expertise with PK, PD, immunogenicity, drug-drug interactions (DDI), bioavailability (BA)/bioequivalence (BE), special populations, and dose selection
Hands-on experience in pharmacometrics (PMx) tools and software (e.g., WinNonlin, NONMEM or Monolix, and R) for individual (e.g., noncompartmental analysis, NCA) and population PK/PD (PopPK/PD) analysis, modeling and simulations (M&S), and exposure-response (E-R)
Knowledge of current practices, regulatory requirements in clinical development, bioanalysis, biopharmaceutics, pharmacology, toxicology, and formulation development
Excellent written and oral communication skills with meticulous attention to detail
Thrives in a dynamic, interactive, fast-paced, innovative, and entrepreneurial environment
Natural collaborator who enjoys working on a cross-functional team
Preferred
Previous experience with monoclonal antibody (mAb) therapeutics in autoimmune diseases
Benefits
Equity and other forms of compensation may be provided as part of a total compensation package
Full range of medical, dental, vision, 401k
Unlimited paid time off
Parental leave
Company
Immunovant
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.86BKey Investors
Roivant Sciences
2025-12-11Post Ipo Equity· $550M
2025-01-13Post Ipo Equity· $450M
2023-09-27Post Ipo Equity· $450M
Recent News
2026-01-11
MarketScreener
2026-01-05
Company data provided by crunchbase